Insider Trading April 20, 2026 05:22 PM

Presurance Holdings director raises stake with $18,397 in purchases

James Grant Smith adds 24,772 shares amid $14 million rights offering and Nasdaq minimum bid notice

By Derek Hwang PRHI
Presurance Holdings director raises stake with $18,397 in purchases
PRHI

James Grant Smith, a director at Presurance Holdings, increased his direct holding by purchasing a total of 24,772 shares of common stock for roughly $18,397 in two transactions in April 2026. The purchases come as Presurance completed a $14 million rights offering and works to cure a Nasdaq minimum bid price deficiency by August 31, 2026.

Key Points

  • Director James Grant Smith purchased 24,772 shares in April 2026 for about $18,397, bringing his direct holding to 60,922 shares - impacts corporate ownership and insider activity monitoring.
  • Presurance completed a $14 million rights offering selling 4,284,640 shares at $1.00 per share, with Clarkston Companies providing additional support by buying 9,715,360 shares under a backstop agreement - affects company capitalization and investor dilution considerations.
  • The company faces a Nasdaq minimum bid price deficiency and must attain a closing bid of at least $1.00 per share for 10 consecutive business days by August 31, 2026 - relevant to exchange compliance and listing status.

James Grant Smith, a member of the board at Presurance Holdings, Inc. (NASDAQ: PRHI), recently expanded his direct stake in the company through two open-market purchases that together amount to approximately $18,397. The acquisitions were executed at prices between $0.74 and $0.80 per share.

According to a Form 4 filing with the Securities and Exchange Commission, Mr. Smith bought 1,100 shares of common stock on April 6, 2026, paying $0.80 per share. A week later, on April 13, 2026, he added another 23,672 shares at $0.74 per share. Combined, these transactions total 24,772 shares and cost roughly $18,397 in aggregate.

Following the April transactions, Mr. Smith now directly holds 60,922 shares of Presurance common stock.


Market context and stock performance

Presurance shares are trading well below the prices at which the director purchased the recent lots. The stock was quoted at $0.59, reflecting a 19% decline over the prior week and a 56% fall over the past six months. Public disclosure sources note that the security generally exhibits high price volatility and the company has remained unprofitable over the trailing twelve months.

Investors seeking more detailed analytics can refer to available Pro Research material on PRHI, which is listed among a coverage universe of more than 1,400 U.S. equities and is accompanied by InvestingPro commentary noting the stock's volatility and recent financial performance.


Corporate financing and compliance update

Presurance recently closed a rights offering that raised $14 million through the sale of 4,284,640 shares at $1.00 per share. Under a backstop arrangement, Clarkston Companies, Inc. purchased an additional 9,715,360 shares.

Separately, the company received a notification from The Nasdaq Stock Market LLC indicating non-compliance with the exchange's minimum bid price requirement. Presurance has until August 31, 2026 to regain compliance by achieving a closing bid price of at least $1.00 per share for 10 consecutive business days.


What is known and limits of the record

The SEC Form 4 provides the transaction specifics and the aggregate holding reported by Mr. Smith. Public filings and company notices detail the rights offering proceeds and the Nasdaq compliance timetable. Information available through InvestingPro highlights volatility and recent unprofitability, but additional context beyond these disclosures is not presented in the filings cited.

Readers should note this article confines itself to those disclosed facts and does not extend beyond the reported transactions, financial figures, or regulatory notices.

Risks

  • Nasdaq compliance risk - Presurance must meet a $1.00 minimum closing bid for 10 consecutive business days by August 31, 2026 to cure a notice of non-compliance, which could affect listing status if not achieved.
  • Price volatility and recent unprofitability - The stock has been highly volatile and unprofitable over the last twelve months, creating greater market risk for investors and capital providers.
  • Share price weakness - The share price was $0.59 at the cited time, down 19% over the past week and 56% over six months, which may limit near-term liquidity and investor confidence.

More from Insider Trading

Bicara Therapeutics CEO Disposes $354,145 in Shares, Exercises Options Amid Stock Rally Apr 20, 2026 Broadwood Partners Completes $652,875 Open-Market Purchases in Insight Molecular Diagnostics Apr 20, 2026 Arista Networks CEO Sells $55.76 Million in Stock via Family Trusts Apr 20, 2026 WEX COO Executes $612,500 Stock Sale; Company Nears 52-Week High Ahead of Earnings Apr 20, 2026 AMREP insiders increase holdings as shares trade near 52-week high Apr 20, 2026